An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease
Andrew B. Munkacsi(Columbia University Irving Medical Center), Stephen L. Sturley(Columbia University), Amy H.Y. Tong(University of Hong Kong), Charles Boone(University of Toronto), Jacob V. Layer(Indiana University – Purdue University Indianapolis), Martin Bard(Indiana University – Purdue University Indianapolis), Giselle Domínguez Gutiérrez(Columbia University Irving Medical Center), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), Matthew Brinkman(Columbia University Irving Medical Center), Fannie W. Chen(Icahn School of Medicine at Mount Sinai), Katsumi Higaki(Tottori University), Jagruti Chaudhari(Icahn School of Medicine at Mount Sinai)
Cited by 91
Related Papers
Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
|Science Translational Medicine|2018|410
Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe
|Journal of Clinical Investigation|2007|372
Transmembrane Molecular Pump Activity of Niemann-Pick C1 Protein
|Science|2000|324